We’re 60 Weeks Into the Weight Loss Drug Revolution. Now What?

By Liz BrodyPublished for Oprah daily on Jan 28, 2025 (…) Of course, that’s still out of reach for many people. Qato’s research in JAMA Health Forum hits on the hard truth of the inequity playing out. While obesity disproportionately affects those on Medicare and Medicaid, in 2023, nearly 90 percent of Wegovy prescription fills…Continue Reading We’re 60 Weeks Into the Weight Loss Drug Revolution. Now What?